Cell/Gene Tx channel feed

Ab­b­Vie drops Cari­bou part­ner­ship on gene-edit­ed CAR-T ther­a­py

9 hours ago
R&D

FDA picks apart Brain­Stor­m's po­ten­tial ALS treat­ment ahead of Wednes­day ad­comm

Yesterday
FDA+

Dana-Far­ber, Brigham breakup could lead to a rip­ple ef­fect for CGT clin­i­cal tri­als for can­cer

4 days ago
In Focus

Q&A: No­vo Nordisk Foun­da­tion’s Celler­a­tor CEO Thomas Carlsen digs in­to $135.4M Dan­ish cell ther­a­py fa­cil­i­ty

5 days ago
Manufacturing

FDA wants to know: What's hold­ing up the de­vel­op­ment of in­di­vid­u­al­ized cell and gene ther­a­pies?

6 days ago
FDA+

Taysha stops de­vel­op­ing a gene ther­a­py amid de­bate over FDA’s stance on ul­tra-rare tri­als

6 days ago
R&D

RNA edit­ing start­up launch­es with $30M based on Stan­ford and Uni­ver­si­ty of Tübin­gen re­search

Last week
Financing
Startups

Plat­form des­ig­na­tions: FDA's new cell and gene ther­a­py su­per of­fice di­rec­tor sees po­ten­tial

Last week
FDA+

Ex­clu­sive: Backed by Il­lu­mi­na, Bro­ken String Bio­sciences rais­es $15M to find off-tar­get gene ed­its

Last week
Financing
Startups

Not 'TIL' 2024: Io­vance’s li­fileu­cel faces yet an­oth­er ap­proval de­lay, this time due to FDA re­source con­straints

Last week
FDA+

Q&A: Lon­za CGT pres­i­dent Daniel Pal­mac­ci talks man­u­fac­tur­ing amid low­er sales out­look

Last week
Manufacturing

Gene ther­a­py biotech Alveo­Gene launch­es with lentivi­ral plat­form for res­pi­ra­to­ry dis­eases

Last week
Startups
R&D

Roy­al­ty Phar­ma ex­ecs shed light on strat­e­gy be­hind their first gene ther­a­py deal

Last week
Deals

Up­dat­ed: 2sev­en­ty lays off 40% of staff, prunes CAR-T pipeline as Nick Leschly steps down as CEO

2 weeks ago
People

Up­dat­ed: No­var­tis dis­con­tin­ues lead Gy­ro­scope gene ther­a­py af­ter $800M+ buy­out

3 weeks ago
R&D

Ot­su­ka pens AAV deal with Shape Ther­a­peu­tics for eye gene ther­a­pies

3 weeks ago
Deals

Ex­clu­sive: Dana­her’s ven­ture arm backs cell ther­a­py man­u­fac­tur­ing start­up co-found­ed by Carl June

3 weeks ago
Startups
Manufacturing

iP­SC biotech Shore­line Bio­sciences wins patent in­fringe­ment suit over Fate, White­head In­sti­tute

3 weeks ago
Pharma
Law

Bio­Car­dia un­veils in­ter­im da­ta that led it to stop PhI­II en­roll­ment of heart fail­ure stem cell ther­a­py

3 weeks ago
R&D

Beam dos­es first pa­tient with base-edit­ed cell ther­a­py

3 weeks ago
R&D

For­mer Al­lo­gene CFO Er­ic Schmidt talks about his new role at Can­tor and the fu­ture of cell ther­a­pies

3 weeks ago
People

Sana lays off staff as cell ther­a­py biotech awaits first clin­i­cal da­ta

4 weeks ago
People

Cell ther­a­py start­up Notch Ther­a­peu­tics clos­es one of three sites

4 weeks ago
People
Startups

Bay­er's cell ther­a­py unit Blue­Rock Ther­a­peu­tics lays off about 50 em­ploy­ees

Last month
People
1234 Next page Last page
A service from the Financial Times